J. Đoković

Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach

V. Dobričić, S. Savić, D. Randjelović, 2021, Pharmaceutics.

Analysis of three-dimensional interface corner cracks

B. Hadzima, S. Vulović, J. Đoković, 2019, FME Transactions.

Streptococcal toxic shock-like syndrome (TSLS)

L. Nešić, J. Đoković, Z. Todorović, 2012 .

The Impact of the Oil Phase Selection on Physicochemical Properties, Long-Term Stability, In Vitro Performance and Injectability of Curcumin-Loaded PEGylated Nanoemulsions

V. Papadimitriou, A. Xenakis, S. Savić, 2022, Pharmaceutics.

Forecasting maize yield in the Republic of Serbia by using Box-Jenkins methodology

J. Đoković, T. Paunović, M. Munćan, 2019, Ekonomika poljoprivrede.

Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation

I. Nikolić, S. Savić, M. Savić, 2023, Pharmaceutics.

Curcumin Loaded PEGylated Nanoemulsions Designed for Maintained Antioxidant Effects and Improved Bioavailability: A Pilot Study on Rats

V. Stevanovic, I. Nikolić, J. Antić-Stanković, 2021, International journal of molecular sciences.

Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: formulation approach toward improved in vivo performance.

V. Dobričić, S. Savić, D. Randjelović, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: physicochemical, structural and pharmacokinetic performances.

V. Dobričić, S. Savić, Milos Petkovic, 2023, International journal of pharmaceutics.